Cargando…

In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression

Air pollution is a very critical issue worldwide, particularly in developing countries. Particulate matter (PM) is a type of air pollution that comprises a heterogeneous mixture of different particle sizes and chemical compositions. There are various sources of fine PM (PM(2.5)), and the components...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Ching-Chang, Hsieh, Wen-Yeh, Tsai, Chin-Hung, Chen, Cheng-Yi, Chang, Hui-Fang, Lin, Chih-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068560/
https://www.ncbi.nlm.nih.gov/pubmed/29966381
http://dx.doi.org/10.3390/ijerph15071380
_version_ 1783343297114144768
author Cho, Ching-Chang
Hsieh, Wen-Yeh
Tsai, Chin-Hung
Chen, Cheng-Yi
Chang, Hui-Fang
Lin, Chih-Sheng
author_facet Cho, Ching-Chang
Hsieh, Wen-Yeh
Tsai, Chin-Hung
Chen, Cheng-Yi
Chang, Hui-Fang
Lin, Chih-Sheng
author_sort Cho, Ching-Chang
collection PubMed
description Air pollution is a very critical issue worldwide, particularly in developing countries. Particulate matter (PM) is a type of air pollution that comprises a heterogeneous mixture of different particle sizes and chemical compositions. There are various sources of fine PM (PM(2.5)), and the components may also have different effects on people. The pathogenesis of PM(2.5) in several diseases remains to be clarified. There is a long history of epidemiological research on PM(2.5) in several diseases. Numerous studies show that PM(2.5) can induce a variety of chronic diseases, such as respiratory system damage, cardiovascular dysfunction, and diabetes mellitus. However, the epidemiological evidence associated with potential mechanisms in the progression of diseases need to be proved precisely through in vitro and in vivo investigations. Suggested mechanisms of PM(2.5) that lead to adverse effects and chronic diseases include increasing oxidative stress, inflammatory responses, and genotoxicity. The aim of this review is to provide a brief overview of in vitro and in vivo experimental studies of PM(2.5) in the progression of various diseases from the last decade. The summarized research results could provide clear information about the mechanisms and progression of PM(2.5)-induced disease.
format Online
Article
Text
id pubmed-6068560
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60685602018-08-07 In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression Cho, Ching-Chang Hsieh, Wen-Yeh Tsai, Chin-Hung Chen, Cheng-Yi Chang, Hui-Fang Lin, Chih-Sheng Int J Environ Res Public Health Review Air pollution is a very critical issue worldwide, particularly in developing countries. Particulate matter (PM) is a type of air pollution that comprises a heterogeneous mixture of different particle sizes and chemical compositions. There are various sources of fine PM (PM(2.5)), and the components may also have different effects on people. The pathogenesis of PM(2.5) in several diseases remains to be clarified. There is a long history of epidemiological research on PM(2.5) in several diseases. Numerous studies show that PM(2.5) can induce a variety of chronic diseases, such as respiratory system damage, cardiovascular dysfunction, and diabetes mellitus. However, the epidemiological evidence associated with potential mechanisms in the progression of diseases need to be proved precisely through in vitro and in vivo investigations. Suggested mechanisms of PM(2.5) that lead to adverse effects and chronic diseases include increasing oxidative stress, inflammatory responses, and genotoxicity. The aim of this review is to provide a brief overview of in vitro and in vivo experimental studies of PM(2.5) in the progression of various diseases from the last decade. The summarized research results could provide clear information about the mechanisms and progression of PM(2.5)-induced disease. MDPI 2018-07-01 2018-07 /pmc/articles/PMC6068560/ /pubmed/29966381 http://dx.doi.org/10.3390/ijerph15071380 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cho, Ching-Chang
Hsieh, Wen-Yeh
Tsai, Chin-Hung
Chen, Cheng-Yi
Chang, Hui-Fang
Lin, Chih-Sheng
In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression
title In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression
title_full In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression
title_fullStr In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression
title_full_unstemmed In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression
title_short In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression
title_sort in vitro and in vivo experimental studies of pm(2.5) on disease progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068560/
https://www.ncbi.nlm.nih.gov/pubmed/29966381
http://dx.doi.org/10.3390/ijerph15071380
work_keys_str_mv AT chochingchang invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression
AT hsiehwenyeh invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression
AT tsaichinhung invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression
AT chenchengyi invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression
AT changhuifang invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression
AT linchihsheng invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression